The ECVAM Prevalidation Study on the Use of EpiDerm for Skin Corrosivity Testing

Abstract

In 1996 and 1997, ECVAM supported a formal validation study on in vitro methods for predicting skin corrosivity. Two of the in vitro tests included in the study employed human skin models, the Skin2™ ZK1350 and EPISKIN™ models. In the ECVAM validation study, BASF, Huntingdon Life Sciences (HLS) and ZEBET tested the Skin2 human skin model, production of which ceased in October 1996, while the validation study was still in progress. Since both of the skin models had shown basic usefulness for corrosivity testing and, in particular, the EPISKIN corrosivity test had proved to be a scientifically valid test, the three laboratories decided to conduct a study to determine whether another commercially available human skin model, EpiDerm™, could also be successfully used to predict skin corrosivity. The study was performed according to the ECVAM prevalidation scheme, to allow for refinement of the test protocol and the prediction model, as well as for independent assessment of the performance of the refined methodology in a final blind trial in the three laboratories. In phase I of the study, ZEBET (Laboratory 1) drafted a Standard Operating Procedure (SOP), including a prediction model (PM1), and the project plan for the study. It was a major task to simplify an existing EpiDerm test protocol, which used the time-course of cytotoxicity as its endpoint. To evaluate the predictivity of the simplified method, which used only a 3-minute exposure to test chemicals, 50 chemicals representing a wide spectrum of chemical entities were tested, revealing that the test sensitivity was too low (65%), whereas the specificity was very high (88%). In addition, acceptance criteria for the negative and positive controls were established. Before proceeding to the next phase of the study, ZEBET distributed a refined SOP, data-recording software and documentation sheets, which allowed Good Laboratory Practice (GLP)-compliant quality assurance for each assay. The main goal of phase II was to produce sufficient data to assess the reproducibility of the EpiDerm skin corrosivity test after transfer to Laboratory 2 (HLS). Repeated testing of several chemicals in both laboratories revealed excellent intralaboratory and interlaboratory reproducibility. In addition, chemicals classified as “non-corrosive” (NC) with a 3-minute exposure in phase I, were re-tested by ZEBET with extended exposure periods of 1 hour and 4 hours. The test sensitivity could be significantly increased, if chemicals classified NC with a 3-minute exposure were tested with a 1-hour exposure. Before proceeding to the final blind trial, a refined SOP was drafted, according to which all chemicals had to be tested with exposure times of 3 minutes and 1 hour, and data for these two exposure times were used in the refined hierarchical prediction model, PM2. In phase III, the blind trial, BASF (Laboratory 3) joined the study. ECVAM selected 24 chemicals from the test chemical set used in the ECVAM skin corrosivity validation study, and BIBRA International (UK) purchased, coded and di...

An epidermal equivalent assay for identification and ranking potency of contact sensitizers

“…Reconstructed epidermal models (EE) using primary human keratinocytes are currently used to test whether a chemical has irritant/corrosive properties or not (Fentem et al, 1998;Liebsch et al, 2000;Spielmann et al, 2007). The initial protocol for the potency classification was based on the clinical observation that there is a clear role of irritancy in contact sensitization due to the irritant property of many allergens (Agner et al, 2002;Basketter et al, 2007;Bonneville et al, 2007;McLelland et al, 1991).…”

Assuring consumer safety without animals

“…To test chemicals in these assays the material is topically applied to the engineered epidermis (as either a solid or a liquid) and cell viability is subsequently assessed using the MTT (a tetrazolium salt) assay. 17 In some protocols, the measurement of the inflammatory mediator interleukin-1α is included in addition to the measurement of cell viability. An OECD Test Guideline (TG) exists for the use of these 3D skin models for skin corrosion testing (OECD TG 431) 18 and ECVAM statements have recently been published regarding the validation of these models for skin irritation testing.…”

Surfactant‐like Properties of Alkaline Extracts from Wastewater Biosolids

“…viability = 50%). To put that value in perspective, according to the European regulations, a formulation is considered to be corrosive to skin if the viability of keratocytes after 1 h of exposure is less than 15% [39]. The fact that the skin was exposed for longer than 1 h, and still 50% of the cells survived suggest that the formulation is not extremely aggressive against the skin.…”